Skip to main content
Fig. 4 | Stem Cell Research & Therapy

Fig. 4

From: JKAMP inhibits the osteogenic capacity of adipose-derived stem cells in diabetic osteoporosis by modulating the Wnt signaling pathway through intragenic DNA methylation

Fig. 4

Si-Jkamp decreases the osteogenic ability of CON-ASCs. a, b Immunofluorescence staining of RUX2 and OPN proteins in CON-ASCs after 3 days after osteoinduction. c Alizarin red staining of CON-ASCs after 14 days of osteoinduction. d, e ALP staining of CON-ASCs after 3 and 5 days of osteoinduction. d Osteoinduction for 3 days. e Osteoinduction for 5 days

Back to article page